TARNOW MICHAEL M

CIK 00012636472 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001263647

Recent Transactions

50 trades

Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-18$3.87/sh+2,057→ 71,770 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-05-18−5,144→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-05-18−1,028→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-05-18−2,057→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-18$3.67/sh+5,144→ 77,942 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-18$3.67/sh+1,028→ 72,798 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2020-10-28$3.76/sh+5,144→ 74,857 total
Gift
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2020-10-28−10,288→ 69,713 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-10-28−5,144→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-10-28−5,144→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2020-10-28$3.76/sh+5,144→ 80,001 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-06-09−5,144→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2020-06-09$3.52/sh+5,144→ 69,713 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-06-01+10,000→ 10,000 total
Gift
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-11-21−2,057→ 64,569 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-11-21−2,057→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-11-21−5,144→ 0 total
Gift
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-11-21−5,144→ 64,569 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-11-21$3.56/sh+5,144→ 69,713 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-11-21$3.51/sh+2,057→ 66,626 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-09-16+15,000→ 15,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-05-21−2,057→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-05-21$3.21/sh+2,057→ 64,569 total
Gift
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2018-12-21−5,000→ 62,512 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2018-06-21$3.70/sh+5,144→ 60,311 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2018-06-21$3.66/sh+2,057→ 62,368 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2018-06-21$3.07/sh+5,144→ 67,512 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-06-21−5,144→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-06-21−2,057→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-06-21−5,144→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-06-04+15,000→ 15,000 total
Gift
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2017-06-19−1,028→ 55,167 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2017-06-19−1,028→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2017-06-19$3.51/sh+1,028→ 56,195 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2017-06-01+3,500→ 3,500 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2017-06-01+1,250→ 1,250 total
Gift
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2017-01-26−7,201→ 55,167 total
Gift
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2016-12-12−7,202→ 62,368 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2016-12-12$3.21/sh+14,403→ 69,570 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2016-12-12−14,403→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2016-06-02+3,500→ 3,500 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2016-06-02+1,250→ 1,250 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2016-04-28$3.35/sh+1,543→ 56,710 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2016-04-28−1,543→ 0 total
Gift
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2016-04-28−1,543→ 55,167 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-11-02−5,041→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-11-02$5.22/sh+5,041→ 60,208 total
Gift
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-11-02−5,041→ 55,167 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-06-17$4.95/sh+1,543→ 55,167 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-06-17−1,543→ 0 total

Companies

Recent Filings

Address

ENTREMED, INC. 9640 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850

View on SEC.gov